AAAAAA

   
Results: 1-19 |
Results: 19
Real-time quantitative y chromosome-specific PCR (QYCS-PCR) for monitoringhematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation
Authors: Fehse, B Chukhlovin, A Kuhlcke, K Marinetz, O Vorwig, O Renges, H Kruger, W Zabelina, T Dudina, O Finckenstein, FG Kroger, N Kabisch, H Hochhaus, A Zander, AR
Citation: B. Fehse et al., Real-time quantitative y chromosome-specific PCR (QYCS-PCR) for monitoringhematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation, J HEMATH ST, 10(3), 2001, pp. 419-425
Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem celltransplantation from unrelated donors
Authors: Kroger, N Zabelina, T Kruger, W Renges, H Stute, N Durken, M von Finkenstein, FG Erttmann, R Kabisch, H Schafhausen, P Jaburg, N Loliger, C Zander, AR
Citation: N. Kroger et al., Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem celltransplantation from unrelated donors, ANN HEMATOL, 80(4), 2001, pp. 209-215
MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen
Authors: zur Stadt, U Harms, DO Schluter, S Schrappe, M Goebel, U Spaar, H Janka, G Kabisch, H
Citation: U. Zur Stadt et al., MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen, LEUKEMIA, 15(2), 2001, pp. 283-285
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: Results of study Acute Myeloid Leukemia - Berlin-Frankfurt-Munster 93
Authors: Creutzig, U Ritter, J Zimmermann, M Reinhardt, D Hermann, J Berthold, F Henze, G Jurgens, H Kabisch, H Havers, W Reiter, A Kluba, U Niggli, F Gadner, H
Citation: U. Creutzig et al., Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: Results of study Acute Myeloid Leukemia - Berlin-Frankfurt-Munster 93, J CL ONCOL, 19(10), 2001, pp. 2705-2713
Improved treatment results in children with AML: Results of study AML-BFM 93
Authors: Creutzig, U Berthold, F Boos, J Fleischhack, G Gadner, H Gnekow, A Graubner, U Henze, G Hermann, J Imbach, P Jurgens, H Kabisch, H Korholz, D Niemeyer, CM Reinhardt, D Reiter, A Ritter, J Spaar, HJ Zimmermann, M
Citation: U. Creutzig et al., Improved treatment results in children with AML: Results of study AML-BFM 93, KLIN PADIAT, 213(4), 2001, pp. 175-185
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome
Authors: Kroger, N Schetelig, J Zabelina, T Kruger, W Renges, H Stute, N Schrum, J Kabisch, H Siegert, W Zander, AR
Citation: N. Kroger et al., A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome, BONE MAR TR, 28(7), 2001, pp. 643-647
Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients
Authors: Kroger, N Zabelina, T Kruger, W Renges, H Stute, N Kabisch, H Jaburg, N Loliger, C Krull, A Zander, AR
Citation: N. Kroger et al., Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients, BONE MAR TR, 27(4), 2001, pp. 349-354
Denaturing HPLC for identification of clonal T-cell receptor gamma rearrangements in newly diagnosed acute lymphoblastic leukemia
Authors: Stadt, UZ Rischewski, J Schneppenheim, R Kabisch, H
Citation: Uz. Stadt et al., Denaturing HPLC for identification of clonal T-cell receptor gamma rearrangements in newly diagnosed acute lymphoblastic leukemia, CLIN CHEM, 47(11), 2001, pp. 2003-2011
Patient cytomegalovirus seropositivity with or without reactivation is themost important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin
Authors: Kroger, N Zabelina, T Kruger, W Renges, H Stute, N Schrum, J Kabisch, H Schafhausen, P Jaburg, N Loliger, C Schafer, P Hinke, A Zander, AR
Citation: N. Kroger et al., Patient cytomegalovirus seropositivity with or without reactivation is themost important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin, BR J HAEM, 113(4), 2001, pp. 1060-1071
The common deletion 657del5 in the Nibrin gene is not a major risk factor for B or T cell non-Hodgkin lymphoma in a pediatric population
Authors: Rischewski, J von Bismarck, P Kabisch, H Janka-Schaub, G Obser, T Schneppenheim, R
Citation: J. Rischewski et al., The common deletion 657del5 in the Nibrin gene is not a major risk factor for B or T cell non-Hodgkin lymphoma in a pediatric population, LEUKEMIA, 14(8), 2000, pp. 1528-1529
Toxicity and effectivity of high-dose idarubicin during AML induction therapy: Results of a pilot study in children
Authors: Creutzig, U Korholz, D Niemeyer, CM Kabisch, H Graf, N Reiter, A Scheel-Walter, H Bender-Gotze, C Behnisch, W Hermann, J Mann, G Ritter, J Zimmermann, M
Citation: U. Creutzig et al., Toxicity and effectivity of high-dose idarubicin during AML induction therapy: Results of a pilot study in children, KLIN PADIAT, 212(4), 2000, pp. 163-168
Minimal residual disease analysis in acute lymphoblastic leukemia of childhood after an induction therapy without asparaginase
Authors: zur Stadt, U Harms, DO Schluter, S Jorch, N Spaar, HJ Nurnberger, W Volpel, S Gutjahr, P Schrappe, M Janka, G Kabisch, H
Citation: U. Zur Stadt et al., Minimal residual disease analysis in acute lymphoblastic leukemia of childhood after an induction therapy without asparaginase, KLIN PADIAT, 212(4), 2000, pp. 169-173
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia
Authors: Kroger, N Zabelina, T Sonnenberg, S Kruger, W Renges, H Stute, N Finkenstein, F Mayer, U Holstein, K Fiedler, W Colberg, H Sonnen, R Kuse, R Braumann, D Metzner, B del Valle, F Erttmann, R Kabisch, H Zander, AR
Citation: N. Kroger et al., Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia, BONE MAR TR, 26(7), 2000, pp. 711-716
SV40 sequences in human osteosarcoma of German origin
Authors: Heinsohn, S Scholz, RB Weber, B Wittenstein, B Werner, M Delling, G Kempf-Bielack, B Setlak, P Bielack, S Kabisch, H
Citation: S. Heinsohn et al., SV40 sequences in human osteosarcoma of German origin, ANTICANC R, 20(6B), 2000, pp. 4539-4545
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow
Authors: Zander, AR Zabelina, T Kroger, N Renges, H Kruger, W Loliger, C Durken, M Stockschlader, M de Wit, M Wacker-Backhaus, G Bielack, S Jaburg, N Russmann, B Erttmann, R Kabisch, H
Citation: Ar. Zander et al., Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow, BONE MAR TR, 23(9), 1999, pp. 889-893
Early infections in patients undergoing bone marrow or blood stem cell transplantation - a 7 year single centre investigation of 409 cases
Authors: Kruger, W Russmann, B Kroger, N Salomon, C Ekopf, N Elsner, HA Kaulfers, PM Mack, D Fuchs, N Durken, M Kabisch, H Erttmann, R Zander, AR
Citation: W. Kruger et al., Early infections in patients undergoing bone marrow or blood stem cell transplantation - a 7 year single centre investigation of 409 cases, BONE MAR TR, 23(6), 1999, pp. 589-597
Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients
Authors: Durken, M Horstmann, M Bieling, P Erttmann, R Kabisch, H Loliger, C Schneider, EM Hellwege, HH Kruger, W Kroger, N
Citation: M. Durken et al., Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients, BR J HAEM, 106(4), 1999, pp. 1052-1058
Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposomal amphotericin-B
Authors: Kruger, WH Kroger, N Russmann, B Renges, H Kabisch, H Zander, AR
Citation: Wh. Kruger et al., Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposomal amphotericin-B, BONE MAR TR, 22, 1998, pp. S10-S13
Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
Authors: Kroger, N Kruger, W Wacker-Backhaus, G Hegewisch-Becker, S Stockschlader, M Fuchs, N Russmann, B Renges, H Durken, M Bielack, S de Wit, M Schuch, G Bartels, H Braumann, D Kuse, R Kabisch, H Erttmann, R Zander, AR
Citation: N. Kroger et al., Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia, BONE MAR TR, 22(11), 1998, pp. 1029-1033
Risultati: 1-19 |